We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 14th:
Cimpress plc (CMPR - Free Report) : This mass customization services provider, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.8% over the last 60 days.
Focus Financial Partners Inc. : This wealth management services provider, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.
Berry Global Group, Inc. (BERY - Free Report) : This packaging solutions provider, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.8% over the last 60 days.
Arcosa, Inc. (ACA - Free Report) : This manufacturer and marketer of infrastructure-related products and services, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Growth Stocks to Buy for January 14th
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 14th:
Cimpress plc (CMPR - Free Report) : This mass customization services provider, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.8% over the last 60 days.
Cimpress N.V Price and Consensus
Cimpress N.V price-consensus-chart | Cimpress N.V Quote
Cimpress has a PEG ratio of 1.17 compared with 2.16 for the industry. The company possesses a Growth Score of A.
Cimpress N.V PEG Ratio (TTM)
Cimpress N.V peg-ratio-ttm | Cimpress N.V Quote
Focus Financial Partners Inc. : This wealth management services provider, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.
Focus Financial Partners Inc. Price and Consensus
Focus Financial Partners Inc. price-consensus-chart | Focus Financial Partners Inc. Quote
Focus Financial Partners has a PEG ratio of 0.49, compared with 1.28 for the industry. The company possesses a Growth Score of A.
Focus Financial Partners Inc. PEG Ratio (TTM)
Focus Financial Partners Inc. peg-ratio-ttm | Focus Financial Partners Inc. Quote
Berry Global Group, Inc. (BERY - Free Report) : This packaging solutions provider, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.8% over the last 60 days.
Berry Global Group, Inc. Price and Consensus
Berry Global Group, Inc. price-consensus-chart | Berry Global Group, Inc. Quote
Berry Global has a PEG ratio of 0.88, compared with 1.87 for the industry. The company possesses a Growth Score of B.
Berry Global Group, Inc. PEG Ratio (TTM)
Berry Global Group, Inc. peg-ratio-ttm | Berry Global Group, Inc. Quote
Arcosa, Inc. (ACA - Free Report) : This manufacturer and marketer of infrastructure-related products and services, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.
Arcosa, Inc. Price and Consensus
Arcosa, Inc. price-consensus-chart | Arcosa, Inc. Quote
Arcosa has a PEG ratio of 1.40, compared with 1.43 for the industry. The company possesses a Growth Score of B.
Arcosa, Inc. PEG Ratio (TTM)
Arcosa, Inc. peg-ratio-ttm | Arcosa, Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Growth score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>